Saturday, March 17, 2018
Company News: Page (1) of 1 - 01/12/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Sci-Engi-Medco Solutions Inc. Awarded SBIR Phase 1 NCI Contract to Study Its Lead Molecules in Preclinical Model of Triple Negative Breast Cancer
  By PR Newswire This article is no longer available,but here are some related topics.

Page: 1


Tech News
Tech News Feed  -  copy link for RSS news feed


About Video Based Tutorials - Contact Us - Advertise With Us - Privacy Guidelines